Gene · 406953
Papers4,478
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 4,478
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ELOVL2-AS1 suppresses tamoxifen resistance by sponging miR-1233-3p in breast cancer. | Epigenetics | 2023 | 37908128 | PubTator, text mining | PubMed |
| Bcl-B: an "unknown" protein of the Bcl-2 family. | Biol Direct | 2023 | 37899453 | PubTator, text mining | PubMed |
| Circulating microRNA Panels for Detection of Liver Cancers and Liver-Metastasizing Primary Cancers. | Int J Mol Sci | 2023 | 37895131 | PubTator, text mining | PubMed |
| The Role of ncRNAs in the Immune Dysregulation of Preeclampsia. | Int J Mol Sci | 2023 | 37894897 | PubTator, text mining | PubMed |
| MicroRNA Expression Profile in Bone Marrow and Lymph Nodes in B-Cell Lymphomas. | Int J Mol Sci | 2023 | 37894763 | PubTator, text mining | PubMed |
| PTEN, PTENP1, microRNAs, and ceRNA Networks: Precision Targeting in Cancer Therapeutics. | Cancers (Basel) | 2023 | 37894321 | PubTator, text mining | PubMed |
| Chemokine Ligand 2 Promotes Migration in Osteosarcoma by Regulating the miR-3659/MMP-3 Axis. | Biomedicines | 2023 | 37893141 | PubTator, text mining | PubMed |
| In Vitro microRNA Expression Profile Alterations under CDK4/6 Therapy in Breast Cancer. | Biomedicines | 2023 | 37893081 | PubTator, text mining | PubMed |
| Biophysics in tumor growth and progression: from single mechano-sensitive molecules to mechanomedicine. | Oncogene | 2023 | 37864030 | PubTator, text mining | PubMed |
| Phase II trial of nivolumab and metformin in patients with treatment-refractory microsatellite stable metastatic colorectal cancer. | J Immunother Cancer | 2023 | 37852737 | PubTator, text mining | PubMed |
| Role of exosomes in the development, diagnosis, prognosis and treatment of hepatocellular carcinoma. | Mol Med | 2023 | 37848835 | PubTator, text mining | PubMed |
| Primary and acquired resistance to first-line therapy for clear cell renal cell carcinoma. | Cancer Drug Resist | 2023 | 37842234 | PubTator, text mining | PubMed |
| Health position paper and redox perspectives on reactive oxygen species as signals and targets of cardioprotection. | Redox Biol | 2023 | 37839355 | PubTator, text mining | PubMed |
| Epigallocatechin-3-gallate and cancer: focus on the role of microRNAs. | Cancer Cell Int | 2023 | 37838685 | PubTator, text mining | PubMed |
| The Role of Non-Coding RNAs in Myelodysplastic Neoplasms. | Cancers (Basel) | 2023 | 37835504 | PubTator, text mining | PubMed |
| High serum miR-223-3p expression level predicts complete response and prolonged overall survival in multiple myeloma patients undergoing autologous hematopoietic stem cell transplantation. | Front Oncol | 2023 | 37829335 | PubTator, text mining | PubMed |
| Extracellular vesicles in hematological malignancies: EV-dence for reshaping the tumoral microenvironment. | Front Immunol | 2023 | 37822925 | PubTator, text mining | PubMed |
| Updating the therapeutic role of ginsenosides in breast cancer: a bibliometrics study to an in-depth review. | Front Pharmacol | 2023 | 37818185 | PubTator, text mining | PubMed |
| CADM1 impairs the effect of miR-1246 on promoting cell cycle progression in chemo-resistant leukemia cells. | BMC Cancer | 2023 | 37814227 | PubTator, text mining | PubMed |
| Colorectal cancer-associated T cell receptor repertoire abnormalities are linked to gut microbiome shifts and somatic cell mutations. | Gut Microbes | 2023 | 37795995 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406953/papers?page=9